This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Sirona Dental Systems' CEO Discusses Q4 2011 Results - Earnings Call Transcript

And with that, I’ll now turn the program over to Jost Fischer, Chairman and CEO of Sirona Dental Systems.

Jost Fischer

Thanks, John. It is my pleasure to welcome all of you to our fourth quarter and full year 2011 conference call. Joining me today are Jeffery Slovin, President and Simone Blank, Executive Vice President and Chief Financial Officer. I am delighted to report that fiscal 2011 was a year filled with many accomplishments and successes for Sirona.

We posted outstanding financial results, strengthened our balance sheet, introduced exciting new product offerings and had an impressive showing at the International Dental Show in Cologne. The product launch platform for the dental industry. Our success at the IDS helped drive our strong sales performance particularly in the German market where we saw our revenue increase an exceptionally strong 27.4% to $189 million.

Sirona raised its guidance three times over the course of the year and achieved constant currency revenue growth of 16.4%. Our strategy to leverage our financial strength and reinvest it back into targeted areas of the business has proven to be a very wise decision.

We’ve been strong proponents of building a solid foundation that will allow Sirona to keep growing for years to come. The pillars of the strategy are; the continuous development of innovative advancements in dental technology and the expansion of our sales and service infrastructure in attractive markets around the world.

As many of you know, innovation is the hallmark of Sirona. During the year, we invested in industry-leading 56 million in research and development. This investment resulted in multiple new product introductions including Orthophos XG 3D, CEREC 4.0, SINIUS, FaceScan, SIROBoost and a host of others.

We believe strongly in the potential of these innovations and you should expect to see their impact as we move through fiscal 2012 and beyond. We are proud of all of our innovative new products that are poised to once again change the face of dentistry. And we will not rest on our laurels.

2 of 3

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
SYM TRADE IT LAST %CHG

Markets

DOW 17,826.30 -279.47 -1.54%
S&P 500 2,081.18 -23.81 -1.13%
NASDAQ 4,931.8150 -75.9760 -1.52%

Partners Compare Online Brokers

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs